Wearable Respiratory Monitoring: RESP® Biosensor
Continuously measure lung acoustics including cough and wheeze from hospital to home
As Featured In
Meet the RESP® Biosensor
A first-of-its-kind wearable inspired by stethoscope auscultation that allows for continuous, remote monitoring of patients with chronic respiratory diseases: a Holter monitor for the lungs.
For Health Systems
Enhance disease surveillance and management of chronic respiratory diseases
For Life Sciences
Improve understanding and evidence of treatment response in clinical trials
How it Works
An end-to-end validated system for monitoring respiratory patients
RESP® Biosensor
Wearable device passively captures lung sounds and physiological data
RESP® Cloud
Data wirelessly transferred to the cloud for overread and analysis
Patient Reports
Strados provides comprehensive reports to research or clinical teams
The Award-Winning Wearable for Patients with Respiratory Diseases
Privacy & Security
Designed for Daily Life
Low-burden, discreet design aids patient comfort while accurately collecting data in the real world.
Global Experience
Used in patients and subjects in four continents and 35 languages.
Beyond Cough
Extended capabilities beyond cough frequency include intensity, bouts, lung sounds and vitals* for a fuller understanding of patient health.
Clinically Validated Accuracy
*Measurement not FDA-cleared
FAQ
Frequently Asked Questions and Technical Specifications
News & Resources
Strados Labs Introduces Grant Initiative to Accelerate Research into Continuous Lung Sound Monitoring
The new program provides eligible research studies with in-kind support for the use of the RESP® Biosensor system. Philadelphia, PA, March 20, 2025 – Strados Labs, a medical technology company, is announcing the launch of a new grant initiative developed to accelerate...
Regulatory Pathways for Cough Monitoring in Clinical Trials: FDA Validation Requirements Explained
Cough monitoring has emerged as an increasingly common practice in research studies and drug development in recent years to objectively measure changes in subjects' cough. As drug developers consider including cough frequency as an endpoint in their studies,...
Strados Labs Collaborates with Beth Israel Deaconess Medical Center for Innovative Study in Pulmonary Edema
The study will evaluate continuous lung sound monitoring for the early detection of pulmonary edema and prevention of complications in critically ill ICU patients. Philadelphia, PA, February 20, 2025 — Strados Labs, a medical technology company focused on improving...
Let's Talk
Speak to one of our respiratory experts to learn more